Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Phillip Scheinberg, MD, Olga Nunez, RN, Priscila Scheinberg, MS, CCRP, Barbara Weinstein, RN, Colin O. Wu, PhD, Neal S. Young, MD

Blood (2011) 118 (21): 2406.

https://doi.org/10.1182/blood.V118.21.2406.2406

Published: 2011

Journal Articles

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, Barbara Weinstein, RN, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): LBA-4.

https://doi.org/10.1182/blood.V116.21.LBA-4.LBA-4

Published: 2010

Journal Articles

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, CCRP, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): 1167.

https://doi.org/10.1182/blood.V116.21.1167.1167

Published: 2010

Journal Articles

Predicting Response and Survival for Severe Aplastic Anemia Patients Treated with Immunosuppression.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal S. Young, MD

Blood (2007) 110 (11): 1691.

https://doi.org/10.1182/blood.V110.11.1691.1691

Published: 2007

Journal Articles

Long Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Anti-Thymocyte Globulin and Cyclosporine.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal Young, MD

Blood (2007) 110 (11): 1694.

https://doi.org/10.1182/blood.V110.11.1694.1694

Published: 2007

Journal Articles

Marked Improvement in Short- and Long-Term Survival in Severe Aplastic Anemia Patients Treated with Immunosuppression in the Past 18 Years.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal S. Young, MD

Blood (2007) 110 (11): 1698.

https://doi.org/10.1182/blood.V110.11.1698.1698

Published: 2007

Journal Articles

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG), Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF).

Phillip Scheinberg, MD, Olga Nunez, RN, Colin O. Wu, Neal S. Young, MD

Blood (2005) 106 (11): 3758.

https://doi.org/10.1182/blood.V106.11.3758.3758

Published: 2005

Journal Articles

Subclinical EBV and CMV Reactivations Commonly Occur Following Antibody-Based Immunosuppressive Regimens for Patients with Severe Aplastic Anemia.

Phillip Scheinberg, MD, Stephen H. Fischer, PhD, Li Li, Olga Nunez, RN, Colin O. Wu, Neal S. Young, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1428.

https://doi.org/10.1182/blood.V106.11.1428.1428

Published: 2005

NARROW

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Predicting Response and Survival for Severe Aplastic Anemia Patients Treated with Immunosuppression.

Long Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Anti-Thymocyte Globulin and Cyclosporine.

Marked Improvement in Short- and Long-Term Survival in Severe Aplastic Anemia Patients Treated with Immunosuppression in the Past 18 Years.

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG), Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF).

Subclinical EBV and CMV Reactivations Commonly Occur Following Antibody-Based Immunosuppressive Regimens for Patients with Severe Aplastic Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only